Italia markets closed

ILMN Jan 2025 290.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,08000,0000 (0,00%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,0800
Aperto2,0800
Denaro0,0000
Lettera4,7000
Prezzo d'esercizio290,00
Scadenza2025-01-17
Min-Max giorno2,0800 - 2,0800
Contratto - Min-MaxN/D
Volume1
Open Interest166
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera